Publications

5891 Results

E4697: Phase III cooperative group study of yeast-derived granulocyte macrophage colony-stimulating factor (GM-CSF) versus placebo as adjuvant treatment of patients with completely resected stage III-IV melanoma

Authors
DH Lawson;SJ Lee;AH Tarhini;K Margolin;M Ernstoff;JM Kirkwood
Journal / Conference
Journal of Clinical Oncology 28:7s(suppl; abstr 8504); oral presentation
Year
2010
Research Committee(s)
Melanoma
Study Number(s)
E4697

Sorafenib in patients with platinum treated extensive stage small cell lung cancer (SCLC): A Southwest Oncology Group (SWOG 0435) phase II trial

Authors
B Gitlitz;J Moon;B Glisson;H Reimers;M Bury;J Floyd;TK Schulz;PK Sundaram;C Ho;D Gandara
Journal / Conference
Journal of Thoracic Oncology, Nov; 5(11):1835-1840;
Year
2010
Research Committee(s)
Lung
PMID
PMID20881645
PMC
PMC3676180
Study Number(s)
S0435

Objective response rate of unresectable benign meningioma to hydroxyurea: Southwest Oncology Group phase II trial S9811

Authors
L Swinnen;C Rankin;EJ Rushing;L Hutchins;D Damek;G Barger
Journal / Conference
Society of Neuro-Oncology 2010 Annual Scientific Meeting; poster presentation
Year
2010
Research Committee(s)
Brain
Study Number(s)
S9811

Southwest Oncology Group study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukemia [PMID21113977; PMC3058291]

Authors
A Advani;H Gundacker;O Sala-Torra;J Radich;R Lai;ML Slovak;JE Lancet;S Coutre;RK Stuart;M Mims;P Stiff;F Appelbaum
Journal / Conference
British Journal of Haematology, Dec; 151(5):430-434;
Year
2010
Research Committee(s)
Leukemia
Study Number(s)
S0530

Long-term follow-up of autotransplantation trials for multiple myeloma: update of protocols conducted by the intergroupe francophone du myelome, southwest oncology group, and university of arkansas for medical sciences [PMC2834471; PMID20085933]

Authors
B Barlogie;M Attal;J Crowley;F van Rhee;J Szymonifka;P Moreau;B Durie;J Harosseau
Journal / Conference
Journal of Clinical Oncology 28(7):1209-1214
Year
2010
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

In the interest of full disclosure - author's reply [correspondence] [PMID20359663]

Authors
K Albain;W Barlow
Journal / Conference
Lancet Oncology 11(4):315
Year
2010
Research Committee(s)
Breast
Study Number(s)
SWOG-8814

Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803 [PMC2884300; PMID20052723]

Authors
NJ McCleary;D Niedzwiecki;D Hollis;LB Saltz;P Schaefer;R Whittom;A Hantel;A Benson;R Goldberg;JA Meyerhardt
Journal / Conference
Cancer 116(4):957-966
Year
2010
Research Committee(s)
Gastrointestinal
Study Number(s)
C89803

Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. PMID 20332306; PMC2853720

Authors
A Hoque;C Ambrosone;P Goodman;C Tangen;A Kristal;MS Lucia;Q Wang;M Kappil;I Thompson;A Hsing;H Parnes;RM Santella
Journal / Conference
Cancer Prevention Research 3(4):478-483
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Diet, supplement use, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID20693267;PMC2950820

Authors
A Kristal;K Arnold;ML Neuhouser;P Goodman;D Albanes;IM Thompson
Journal / Conference
American Journal of Epidemiology 172(5):566-577
Year
2010
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Editorial Comment

Authors
IM Thompson
Journal / Conference
Urology 75(3):509-510
Year
2010
Research Committee(s)
Cancer Control, Prevention, Screening, and and Surveillance
Study Number(s)
S0000, SWOG-9217